Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

1.5K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.5K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

1.6K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.6K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

789
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
789
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

670
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
670
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria.

Journal of nephrology·2026
Same author

Prediction of relapses in patients with small vessel vasculitides: a multicenter cohort study on histopathological risk patterns.

Rheumatology international·2025
Same author

Remission induction therapies and long-term outcomes in granulomatosis with polyangiitis and microscopic polyangiitis: real-world data from a European cohort.

Rheumatology international·2024
Same author

Distinct pulmonary patterns in ANCA-associated vasculitides: insights from a retrospective single center cohort study.

Rheumatology international·2024
Same author

Corrigendum to "International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology." Kidney International, 2023;104:36-45.

Kidney international·2023
Same author

[IgA nephropathy].

Innere Medizin (Heidelberg, Germany)·2023
Same journal

Chronic hyponatraemia with a reset osmostat: when abnormal is normal.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Clinical value of repeat kidney biopsy in pediatric IgA vasculitis nephritis.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

The European Society of Pediatric Nephrology Board Examination-a certified benchmark of knowledge and clinical practice with global recognition.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

A rare but misleading cause of hematuria in hemophilia A: renal pelvic hemorrhage mimicking tumor.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Diastolic echocardiographic parameters identify pediatric kidney transplant recipients with structural myocardial alterations.

Pediatric nephrology (Berlin, Germany)·2026
Same journal

Pediatric clinician perspectives on clinical decision support tools for chronic kidney disease risk after preterm birth.

Pediatric nephrology (Berlin, Germany)·2026
See all related articles

Related Experiment Video

Updated: Mar 6, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.2K

Inflammation in IgA nephropathy.

Thomas Rauen1, Jürgen Floege2

  • 1Division of Nephrology and Clinical Immunology, RWTH Aachen University, Pauwelsstr. 30, 52057, Aachen, Germany.

Pediatric Nephrology (Berlin, Germany)
|March 16, 2017
PubMed
Summary
This summary is machine-generated.

Immunoglobulin A nephropathy (IgAN) is common, but immunosuppression benefits are unclear. Supportive care is crucial for managing IgAN progression before considering immunosuppressive therapies.

Keywords:
CorticosteroidsGlomerulonephritisIgA nephropathyImmunosuppressionSupportive therapy

More Related Videos

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.9K
Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.4K

Related Experiment Videos

Last Updated: Mar 6, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

2.2K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.9K
Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
08:43

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice

Published on: January 31, 2020

7.4K

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Background:

  • Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis globally.
  • Current therapeutic guidelines lack strong evidence, especially regarding immunosuppression's role beyond supportive care.
  • Pathogenesis involves defective IgA1 glycosylation, autoantibodies, and immune complex deposition, suggesting an autoimmune component.

Purpose of the Study:

  • To review the pathogenetic mechanisms of IgAN.
  • To critically evaluate the necessity and efficacy of immunosuppressive therapy in adult IgAN patients.
  • To discuss current and potential treatment strategies, including supportive measures and immunosuppression.

Main Methods:

  • Literature review focusing on IgAN pathogenesis, genetic studies, and clinical trial data.
  • Analysis of the
  • multi-hit
  • theory and its implications for treatment.
  • Discussion of evidence supporting or refuting immunosuppressive therapy in IgAN.

Main Results:

  • The
  • multi-hit
  • theory provides a framework for understanding IgAN development, supported by genetic findings.
  • Many adult IgAN patients may not require or benefit from immunosuppression.
  • Optimized supportive measures are highly effective in reducing disease progression risk.

Conclusions:

  • The role of immunosuppression in IgAN requires further investigation, with a strong emphasis on optimizing supportive care first.
  • Understanding the autoimmune component is key, but its clinical translation into widespread immunosuppressive treatment is not yet established for most adult patients.
  • Treatment strategies should be individualized, considering disease severity and patient characteristics, with specific considerations for pediatric populations.